Company Profile
Genmab Stock Price, News & Analysis
- Ticker:
- GMAB
- Exchange:
- NASDAQ
- Sector:
- 双特异性抗体技术平台,HexaBody技术平台,DuoBody技术平台
- Location:
- Headquartered in the United States and listed on NASDAQ, Genmab is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
25.94 USD (+1.29%)
Close
Last updated: June 23, 2026 at 00:00
15.93B USD
Market cap
Why the stock is moving
GMAB is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Genmab is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Genmab is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Genmab follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Genmab sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Genmab (GMAB)?
Genmab (GMAB) most recently closed at 25.94 USD, a +1.29% move versus the previous session.
What is the market cap of Genmab (GMAB)?
Genmab currently has a market capitalization of 15.93B USD on BioPharmSignal.
What does Genmab do?
Genmab is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is GMAB stock listed?
Genmab (GMAB) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Genmab is followed within the biotech universe for its exposure to catalyst-driven execution., 双特异性抗体技术平台,HexaBody技术平台,DuoBody技术平台.
What is Genmab?
Genmab is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Genmab targeting with Genmab?
Genmab is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.